First Light Asset Management, LLC Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$364.7B
Holdings
52
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (52 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NEONEOGENOMICS INC | 3,847,602 | $34.1B | 9.35% | |
| 2 | NKTREURNEKTAR THERAPEUTICS | 351,741 | $21.0B | 5.76% | |
| 3 | ARRYEURARRAY BIOPHARMA INC | 1,566,804 | $20.1B | 5.50% | |
| 4 | ATRCATRICURE INC | 1,075,447 | $19.6B | 5.38% | |
| 5 | —ENTELLUS MEDICAL INC | 670,904 | $16.4B | 4.49% | |
| 6 | OMCLOMNICELL INC | 317,331 | $15.4B | 4.22% | |
| 7 | LGNDLIGAND PHARMACEUTICALS INC | 111,971 | $15.3B | 4.20% | |
| 8 | HBIOHARVARD BIOSCIENCE INC | 4,638,651 | $15.3B | 4.20% | |
| 9 | —IMMUNOMEDICS INC | 944,404 | $15.3B | 4.19% | |
| 10 | MODNEURMODEL N INC | 944,125 | $14.9B | 4.08% | |
| 11 | XNCRXENCOR INC | 644,764 | $14.1B | 3.88% | |
| 12 | —SHIRE PLC | 79,607 | $12.3B | 3.39% | |
| 13 | NVROEURNEVRO CORP | 155,904 | $10.8B | 2.95% | |
| 14 | CSIIEURCARDIOVASCULAR SYSTEMS INC | 444,004 | $10.5B | 2.88% | |
| 15 | HALOHALOZYME THERAPEUTICS INC | 467,646 | $9.5B | 2.60% | |
| 16 | —OXFORD IMMUNOTEC GLOBAL PLC | 596,778 | $8.3B | 2.29% | |
| 17 | DVAXDYNAVAX TECHNOLOGIES CORP | 415,573 | $7.8B | 2.13% | |
| 18 | HRTXHERON THERAPEUTICS INC | 413,721 | $7.5B | 2.05% | |
| 19 | GMEDGLOBUS MEDICAL INC | 176,457 | $7.3B | 1.99% | |
| 20 | —BLUEBIRD BIO INC | 37,838 | $6.7B | 1.85% | |
| 21 | CDXSCODEXIS INC | 804,224 | $6.7B | 1.84% | |
| 22 | —INTERSECT ENT INC | 178,896 | $5.8B | 1.59% | |
| 23 | —TELIGENT INC | 1,503,127 | $5.5B | 1.50% | |
| 24 | QDELUSDQUIDEL CORP | 119,901 | $5.2B | 1.43% | |
| 25 | VCYTVERACYTE INC | 791,337 | $5.2B | 1.42% | |
| 26 | TECHBIO TECHNE CORP | 38,071 | $4.9B | 1.35% | |
| 27 | —K2M GROUP HOLDINGS INC | 270,758 | $4.9B | 1.34% | |
| 28 | HSTMHEALTHSTREAM INC | 209,587 | $4.9B | 1.33% | |
| 29 | —NXSTAGE MEDICAL INC | 192,670 | $4.7B | 1.28% | |
| 30 | LHCGUSDLHC GROUP INC | 68,807 | $4.2B | 1.16% | |
| 31 | VRTXVERTEX PHARMACEUTICALS INC | 23,057 | $3.5B | 0.95% | |
| 32 | BMRNBIOMARIN PHARMACEUTICAL INC | 31,213 | $2.8B | 0.76% | |
| 33 | IRIXIRIDEX CORP | 317,799 | $2.4B | 0.66% | |
| 34 | —STREAMLINE HEALTH SOLUTIONS | 1,375,044 | $2.3B | 0.64% | |
| 35 | IBBISHARES NASDAQ BIOTECHNOLOGY ETF | 21,291 | $2.3B | 0.62% | |
| 36 | ISIIONIS PHARMACEUTICALS INC | 41,847 | $2.1B | 0.58% | |
| 37 | ENZBENZO BIOCHEM INC | 237,054 | $1.9B | 0.53% | |
| 38 | —POWERSHARES S&P SMALLCAP HEALTH CARE ETF | 17,285 | $1.7B | 0.47% | |
| 39 | ALKSALKERMES PLC | 29,533 | $1.6B | 0.44% | |
| 40 | XLVHEALTH CARE SELECT SECTOR SPDR ETF | 18,241 | $1.5B | 0.41% | |
| 41 | LMATLEMAITRE VASCULAR INC | 46,119 | $1.5B | 0.40% | |
| 42 | CELGCELGENE CORP | 13,512 | $1.4B | 0.39% | |
| 43 | MGNXMACROGENICS INC | 73,558 | $1.4B | 0.38% | |
| 44 | IHIISHARES US MEDICAL DEVICES ETF | 7,580 | $1.3B | 0.36% | |
| 45 | XBISPDR S&P BIOTECH ETF | 9,499 | $806.0M | 0.22% | |
| 46 | ABBVABBVIE | 4,159 | $402.0M | 0.11% | |
| 47 | PFEPFIZER INC | 8,558 | $310.0M | 0.09% | |
| 48 | JNJJOHNSON AND JOHNSON | 2,183 | $305.0M | 0.08% | |
| 49 | DYNTQDYNATRONICS CORP | 104,379 | $301.0M | 0.08% | |
| 50 | NVSNNOVARTIS A G | 3,572 | $300.0M | 0.08% | |
| 51 | SNYSANOFI-SYNTHELABO | 6,720 | $289.0M | 0.08% | |
| 52 | MRKMERCK & CO INC | 4,294 | $242.0M | 0.07% |